Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-01-24

Clinical Trial Update: T-Cell Vaccination in Multiple Sclerosis (MS) [Phase 1, Phase 2]

View source ↗

Summary

Update on a T-cell vaccination approach being explored for multiple sclerosis in Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sheba Medical Center | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN